Company Description
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems.
It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems.
In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices.
Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices.
It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
| Country | United States |
| Founded | 1990 |
| IPO Date | Aug 12, 2004 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 131 |
| CEO | David Fischel |
Contact Details
Address: 710 North Tucker Boulevard, Suite 110 Saint Louis, Missouri 63101 United States | |
| Phone | 314 678 6100 |
| Website | stereotaxis.com |
Stock Details
| Ticker Symbol | STXS |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001289340 |
| CUSIP Number | 85916J409 |
| ISIN Number | US85916J4094 |
| Employer ID | 94-3120386 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A. | Chief Executive Officer and Chairman |
| Keith Galloway | Vice President of Operations |
| Patricia S. Williams Esq. | General Counsel and Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 13, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Mar 12, 2026 | 10-K | Annual Report |
| Mar 9, 2026 | 8-K | Current Report |
| Nov 12, 2025 | 10-Q | Quarterly Report |
| Nov 12, 2025 | 8-K | Current Report |
| Aug 29, 2025 | 424B5 | Filing |
| Aug 29, 2025 | 8-K | Current Report |
| Aug 13, 2025 | 10-Q | Quarterly Report |
| Aug 7, 2025 | 8-K | Current Report |
| Jul 18, 2025 | 424B5 | Filing |